Progenis Pharmaceuticals is a biotechnology company based in Perth, Western Australia, pioneering the development of next-generation RNA therapeutics. The company specializes in precision RNA medicines, especially antisense oligonucleotide (ASO) therapies, aimed at treating a broad range of acquired and genetic rare diseases. Their approach focuses on innovation, safety, efficacy, and accessibility to provide effective disease-modifying therapeutics for patients worldwide.
Is this your organisation?
Claim this profile to add your story, team and milestones.